Revance to Release Fourth Quarter and Full Year 2019 Financial Results on Monday, February 24, 2020
Conference Call Scheduled for Monday, February 24, 2020 at 4:30 p.m. ET NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…
Pharmaceuticals, Biotechnology and Life Sciences
Conference Call Scheduled for Monday, February 24, 2020 at 4:30 p.m. ET NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on…
DUBLIN–(BUSINESS WIRE)–The “Drafting Commercial Contracts for the Pharmaceutical Industry” conference has been added to ResearchAndMarkets.com’s offering. This unique and highly…
Accelerated Approval Pathway Defined for Mirvetuximab Soravtansine in Ovarian Cancer; Pivotal SORAYA Trial Expected to Enroll First Patient in Q1…
First Study to Explore a Treat-to-Target Strategy in Crohn’s Disease using Endoscopy to Guide Dose Adjustment First Study to Evaluate…
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the human insulin drugs market in Brazil and it is poised to grow by USD…
HERCULES, Calif.–(BUSINESS WIRE)–In the press release’s forward-looking statement, the second sentence should read: …for the full year 2020 anticipating currency-neutral revenue growth of…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that it has agreed to purchase…
MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, today announced the closing of its previously announced underwritten…
Cassel’s capabilities amplify TASI Packaging Integrity Group’s customer-focused mission to help ensure packaging quality, protecting end-users worldwide MARLBOROUGH, Mass. &…